Hybrid nano-stimulator for specific amplification of oxidative stress and precise tumour treatment.
J Drug Target
; 32(7): 756-769, 2024 Aug.
Article
em En
| MEDLINE
| ID: mdl-38832845
ABSTRACT
BACKGROUND:
The use of reactive oxygen species (ROS) to target cancer cells has become a hot topic in tumor therapy.PURPOSE:
Although ROS has strong cytotoxicity against tumor cells, the key issue currently is how to generate a large amount of ROS within tumor cells.METHODS:
Organic/inorganic hybrid nanoreactor materials combine the advantages of organic and inorganic components and can amplify cancer treatment by increasing targeting and material self-action. The multifunctional organic / inorganic hybrid nanoreactor is helpful to overcome the shortcomings of current reactive oxygen species in cancer treatment. It can realize the combination of in situ dynamic therapy and immunotherapy strategies, and has a synergistic anti-tumor effect.RESULTS:
This paper reviews the research progress of organic/inorganic hybrid nanoreactor materials using tumor components to amplify reactive oxygen species for cancer treatment. The article reviews the tumor treatment strategies of nanohybrids from the perspectives of cancer cells, immune cells, tumor microenvironment, as well as 3D printing and electrospinning techniques, which are different from traditional nanomaterial technologies, and will arouse interest among scientists in tumor therapy and nanomedicine.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Espécies Reativas de Oxigênio
/
Estresse Oxidativo
/
Neoplasias
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article